Skip to navigation Skip to content

Share

Master Page Does Not Exist

    Services

    Master Page Does Not Exist
    1. Your selection returned no results. Please select another category, check our calendar of events, or call an MS Navigator at 1-800-344-4867

    Resources

    Master Page Does Not Exist
    1. Promising MS Research - Recorded Webcast

      Promising MS Research to Repair, Protect and Restore the Nervous System. Moderator Kate Milliken and panelists Dr. Ben Barres, Dr. Jonah Chan, Dr. Timothy Coetzee and Dr. Rhonda Voskuhl. December 5, 2013

    2. Clinical Trials in MS

      Large Phase 3 trials in RR MS. Updated September 2013. Abbreviations Key: AAN – American Academy of Neurology. CIS – Clinically Isolated Syndrome.

    3. Find Clinical Trials

      Clinical trials help to find solutions for everyone affected by MS. Find studies near you.

    4. From Clinical Trials to Treatments

      This presentation is: From Clinical Trials to Treatments.

    5. Symptomatic Treatment Trials

      This document outlines Symptomatic Treatment Trials.

    6. MS Top 10 Therapies Research Update (Teleconference recording)

      During this teleconference participants will: Understand the risks and benefits of different treatment options; Learn about new treatments on the horizon; Understand how different treatment options compare to each other. The speaker, Dr. Graesser, specializes in MS and in addition to general neurology cases, she also provides care for movement disorders, headaches, and neurologic disorders in pregnancy.

    7. MS Research Using Vision (OCT) Testing: Anti-LINGO-1 (video)

      Neuro-opthalmologist Tariq Bhatti, MD, at Duke University Eye Center, discusses the use of optical coherence tomography (OCT) in evaluating multiple sclerosis (MS) progression and the effects of treatments - namely anti-LINGO-1.

Share

Master Page Does Not Exist
© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.